Cargando…
Cancer immunotherapy comes of age and looks for maturity
As Nature Communications celebrates a 10-year anniversary, the field has witnessed the transition of cancer immunotherapy from a pipe dream to an established powerful cancer treatment modality. Here we discuss the opportunities and challenges for the future.
Autores principales: | Finck, Amanda, Gill, Saar I., June, Carl H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335079/ https://www.ncbi.nlm.nih.gov/pubmed/32620755 http://dx.doi.org/10.1038/s41467-020-17140-5 |
Ejemplares similares
-
Single cell transcriptomics comes of age
por: Aldridge, Sarah, et al.
Publicado: (2020) -
The coming of age of the pediatric EBMT criteria
por: Corbacioglu, Selim
Publicado: (2020) -
The cell biology of microbial infections: coming of age
por: Galán, Jorge E.
Publicado: (2002) -
Will the COVID-19 crisis trigger a One Health coming-of-age?
por: de Garine-Wichatitsky, Michel, et al.
Publicado: (2020) -
Open notes in cancer care: coming soon to patients
por: Blease, Charlotte, et al.
Publicado: (2020)